학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 140건 | 목록 1~20
Conference
Jensen, K Y, Nabi, H, Jensen, D V, Pedersen, J, Hendricks, O, Loft, A G, Colic, A, Danebod, K, Kristensen, S, Munk, H, Lomborg, N, Manilo, N, Chrysidis, S, Just, S, Linauskas, A, Højgaard, P, Thygesen, P H, Kildemand, M, Østgård, R D, Hetland, M L & Glintborg, B 2024, 'Adalimumab Biosimilar-to-biosimilar Switch in Patients with Inflammatory Rheumatic Diseases – Real-world Evidence from the Nationwide Danish Registry, DANBIO', Arthritis & Rheumatology, vol. 76, no. Suppl. 9, pp. 2046-2049. < https://acrabstracts.org/abstract/adalimumab-biosimilar-to-biosimilar-switch-in-patients-with-inflammatory-rheumatic-diseases-real-world-evidence-from-the-nationwide-danish-registry-danbio/ >
Jensen, K Y, Nabi, H, Jensen, D V, Pedersen, J, Hendricks, O, Loft, A G, Colic, A, Danebod, K, Kristensen, S, Munk, H, Lomborg, N, Manilo, N, Chrysidis, S, Just, S, Linauskas, A, Højgaard, P, Thygesen, P H, Kildemand, M, Østgård, R D, Hetland, M L & Glintborg, B 2024, ' Adalimumab Biosimilar-to-biosimilar Switch in Patients with Inflammatory Rheumatic Diseases – Real-world Evidence from the Nationwide Danish Registry, DANBIO ', Arthritis & Rheumatology, vol. 76, no. Suppl. 9, pp. 2046-2049 . < https://acrabstracts.org/abstract/adalimumab-biosimilar-to-biosimilar-switch-in-patients-with-inflammatory-rheumatic-diseases-real-world-evidence-from-the-nationwide-danish-registry-danbio/ >
Academic Journal
Nabi, H, Georgiadis, S, Loft, A G, Hendricks, O, Jensen, D V, Andersen, M, Chrysidis, S, Colic, A, Danebod, K, Hussein, M R, Kalisz, M H, Kristensen, S, Lomborg, N, Manilo, N, Munk, H L, Pedersen, J K, Raun, J L, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2021, 'Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab : Nationwide observational study emulating a randomised clinical trial', Annals of the Rheumatic Diseases, vol. 80, no. 11, pp. 1400-1409. https://doi.org/10.1136/annrheumdis-2021-219951
Nabi, H, Georgiadis, S, Loft, A G, Hendricks, O, Jensen, D V, Andersen, M, Chrysidis, S, Colic, A, Danebod, K, Hussein, M R, Kalisz, M H, Kristensen, S, Lomborg, N, Manilo, N, Munk, H L, Pedersen, J K, Raun, J L, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2021, ' Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab : Nationwide observational study emulating a randomised clinical trial ', Annals of the rheumatic diseases, vol. 80, no. 11, pp. 1400-1409 . https://doi.org/10.1136/annrheumdis-2021-219951
Conference
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J, Just, S, Danebod, K, Munk, H, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, 'Biosimilar-to-Biosimilar Switching in Routine Care-Results on > 1,600 Patients with Inflammatory Arthritis in the DANBIO Registry', Arthritis & Rheumatology, vol. 74, no. Suppl. 9, 1112, pp. 2209-2211.
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J, Just, S, Danebod, K, Munk, H, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Biosimilar-to-Biosimilar Switching in Routine Care-Results on > 1,600 Patients with Inflammatory Arthritis in the DANBIO Registry ', Arthritis & Rheumatology, vol. 74, no. Suppl. 9, 1112, pp. 2209-2211 .
Conference
Nabi, H, Glintborg, B, Loft, A G, Hendricks, O, Pedersen, J K, Just, S A, Ahmed, R, Danebod, K, Munk, H, Colic, A, Linauskas, A, Jensen, D V, Raun, J, Grydehøj, J, Christensen, L B, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, N S & Hetland, M 2021, 'Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111', ACR Convergence 2021, 03/11/2021-09/11/2021 pp. 1161-1163. < https://acrabstracts.org/abstract/biosimilar-to-biosimilar-infliximab-switching-in-real-world-patients-with-inflammatory-arthritis-followed-in-the-danish-danbio-registry-switch-from-originator-infliximab-to-ct-p13-and-then-to-gp1111/ >
Nabi, H, Glintborg, B, Loft, A G, Hendricks, O, Pedersen, J K, Just, S A, Ahmed, R, Danebod, K, Munk, H, Colic, A, Linauskas, A, Jensen, D V, Raun, J, Grydehøj, J, Christensen, L B, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, N S & Hetland, M 2021, ' Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111 ', ACR Convergence 2021, 03/11/2021-09/11/2021 pp. 1161-1163 . < https://acrabstracts.org/abstract/biosimilar-to-biosimilar-infliximab-switching-in-real-world-patients-with-inflammatory-arthritis-followed-in-the-danish-danbio-registry-switch-from-originator-infliximab-to-ct-p13-and-then-to-gp1111/ >
Conference
Nabi, H, Glintborg, B, Loft, A G, Hendricks, O, Pedersen, J K, Just, S A, Ahmed, R, Danebod, K, Munk, H L, Colic, A, Linauskas, A, Jensen, D V, Christensen, L B, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, N S & Hetland, M L 2021, 'Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry', Scandinavian Journal of Rheumatology, vol. 50, no. Suppl. 130, pp. 14-15.
Nabi, H, Glintborg, B, Loft, A G, Hendricks, O, Pedersen, J K, Just, S A, Ahmed, R, Danebod, K, Munk, H L, Colic, A, Linauskas, A, Jensen, D V, Christensen, L B, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, N S & Hetland, M L 2021, ' Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry ', Scandinavian Journal of Rheumatology, vol. 50, no. Suppl. 130, pp. 14-15 .
Nabi, H, Glintborg, B, Loft, A G, Hendricks, O, Pedersen, J K, Just, S A, Ahmed, R, Danebod, K, Munk, H L, Colic, A, Linauskas, A, Jensen, D V, Christensen, L B, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, N S & Hetland, M L 2021, ' Multiple infliximab biosimilar switches : results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry ', Scandinavian Journal of Rheumatology, vol. 50, no. Suppl. 130, OP16, pp. 14-15 . < https://doi.org/10.1080/03009742.2021.1951065 >
Nabi, H, Glintborg, B, Loft, A G, Hendricks, O, Pedersen, J K, Just, S A, Ahmed, R, Danebod, K, Munk, H L, Colic, A, Linauskas, A, Jensen, D, Christensen, L, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, N S & Hetland, M L 2021, ' Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111 in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry ', EULAR 2021 Virtual Congress, 02/06/2021-05/06/2021 .
Academic Journal
Lomborg, N & Lottenburger, T 2021, ' Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis ', Ugeskrift for Laeger, bind 182, nr. 4, V03200200 . < https://ugeskriftet.dk/videnskab/komplet-remission-ved-behandling-med-jak-haemmer-hos-en-patient-med-alopeciatotalis >
Academic Journal
Lomborg, N, Marcussen, N & Junker, P 2014, ' Retroperitoneal fibrosis as the presenting manifestation of IgG4-related disease in a patient previously diagnosed with granulomatosis with polyangiitis (Wegener's) : one disease or two? ', Scandinavian Journal of Rheumatology, vol. 43, no. 4, pp. 345-347 . https://doi.org/10.3109/03009742.2014.905628
Conference
Just, S A, Asmussen Andreasen, R, Lomborg, N, Gildberg-Mortensen, R, Weihe, J P & Jensen Hansen, I M 2014, ' Inflammation, Vitamin D and bone mineral density in patients presenting with Giant ell Vasculitis and/or Polymyalgia rheumatica: A retrospective cross-sectional study ', 35th Scandinavian Congress of Rheumatology, Stokholm, Sweden, 20/09/2014-23/09/2014 .
Conference
Asmussen Andreasen, R, Andersen, N S, Just, S A, Lomborg, N & Jensen Hansen, I M 2014, ' Septic arthritis in the central part of Denmark ', The 15th Annual European Congress of Rheumatology EULAR 2014, Paris, France, 11/06/2014-14/06/2014 .
검색 결과 제한하기
제한된 항목
[검색어] Lomborg, Niels
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어